Watchlist Price Alert

Geron Corporation (GERN)

NASDAQ: GERN · Real-Time Price · USD

1.56

0.02 (1.30%)

At close: Jun 05, 2025, 3:59 PM

1.30% (1D)

Bid	1.51
Market Cap	993.59M
Revenue (ttm)	116.29M
Net Income (ttm)	-139.02M
EPS (ttm)	-0.21
PE Ratio (ttm)	-7.43
Forward PE	-38.25
Analyst	Buy

Ask	1.61
Volume	9,236,054
Avg. Volume (20D)	13,160,304
Open	1.52
Previous Close	1.54
Day's Range	1.50 - 1.56
52-Week Range	1.17 - 5.34
Beta	0.68

About GERN

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol GERN

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for GERN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

3 months ago

-32.07%

Geron Corporation shares are trading lower. The co... Unlock content with Pro Subscription

10 months ago

-7.14%

Geron shares are trading lower after the company announced the departure of CCO Anil Kapur.

News

2 days ago · seekingalpha.com

Conservative Vision Of A Positive Future For Geron

This is a follow-up coverage of the Geron Corp., a small biotech company that markets first-in-class drug Imetelstat for the treatment of myelodysplastic syndrome (MDS). The first three full-quarter s...

1 week ago · businesswire.com

Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program

FOSTER CITY, Calif.--(BUSINESS WIRE)---- $GERN--Geron announces presentations on RYTELO® (imetelstat) at 2025 ASCO Annual Meeting and EHA 2025 Congress.

2 weeks ago · businesswire.com

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted equity awards covering an aggregate of 411,000 ...

3 weeks ago · accessnewswire.com

Geron Corporation Class Action: Levi & Korsinsky Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 - GERN

NEW YORK, NY / ACCESS Newswire / May 12, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities laws...

NEW YORK CITY, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Geron C...

3 weeks ago · accessnewswire.com

Levi & Korsinsky Reminds Geron Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 - GERN

NEW YORK, NY / ACCESS Newswire / May 11, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities laws...